Valuation AstraZeneca PLC Nasdaq Stockholm

Stocks

Real-time Estimate Cboe Europe 08:47:56 2026-10-09 EDT			5-day change	1st Jan Change
1,592.25 ^SEK	+1.13%		+1.21%	-6.49%

08:57pm	Daiichi Sankyo, AstraZeneca's Datroway Gets China's Approval for Second Breast Cancer Indication	MT
10-08	Guardant Gets European Approval for Guardant360 as Companion Diagnostic for AstraZeneca's Etcamah in Breast Cancer	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	243,737	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-15.31%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	263,782	256,112	247,475
Change	-	12.57%	-0.25%	-1.74%	36.64%	-15.23%	-2.91%	-3.37%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	20.3x	17.4x	15.5x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.5x	3.91x	3.37x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1x	1.2x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	3.85x	3.63x	3.42x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.17x	3.81x	3.47x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	11.9x	10.5x	9.22x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	12.5x	11.1x	9.71x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	27.5x	19.8x	17x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.63%	5.05%	5.89%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.34	3.544	3.655
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	2.13%	2.26%	2.33%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.735	9.027	10.16
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	43.2%	39.3%	36%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,317	67,203	71,327
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,084	24,331	26,828
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,045	23,173	25,485
Net income ¹	112	3,288	5,961	7,035	10,225	11,897	13,838	15,530
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	20,045	12,375	3,738
Reference price ²	117.51	135.16	135.02	131.05	185.60	157.15	157.15	157.15
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.21x	12.07x	24.51x	0.59%	1,043B
JOHNSON & JOHNSON	28.53x	6.31x	18.08x	2.08%	618B
ABBVIE INC.	34.51x	8.02x	16.59x	2.55%	481B
MERCK & CO., INC.	103.58x	5.8x	24.76x	2.4%	351B
ROCHE HOLDING AG	19.03x	4.65x	11.56x	2.84%	338B
NOVARTIS AG	19.78x	5.2x	12.8x	3.06%	269B
ASTRAZENECA PLC	20.32x	4.17x	11.93x	2.13%	244B
AMGEN INC.	25.73x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.49x	6.55x	25.51x	2.24%	182B
Average	26.69x	6.61x	17.52x	2.26%	416.3B
Weighted average by Cap.	31.90x	7.75x	18.94x	1.93%